Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus

被引:129
作者
Schlicker, E [1 ]
Timm, J [1 ]
Zentner, J [1 ]
Gothert, M [1 ]
机构
[1] UNIV BONN,NEUROCHIRURG KLIN,D-53105 BONN,GERMANY
关键词
cannabinoid CB1 receptors; human hippocampus; guinea-pig hippocampus; noradrenaline release; presynaptic receptors; cAMP accumulation; WIN 55,212-2; SR; 141716;
D O I
10.1007/PL00005093
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We examined the question of whether cannabinoid receptors modulating noradrenaline release are detectable in the brain of humans and experimental animals. For this purpose, hippocampal slices from humans, guinea-pigs, rats and mice and cerebellar, cerebrocortical and hypothalamic slices from guinea-pigs were incubated with [H-3]noradrenaline and then superfused. Tritium overflow was evoked either electrically (0.3 or 1 Hz) or by introduction of Ca2+ ions (1.3 mu M) into Ca2+-free, K+-rich medium (25 mu M) containing tetrodotoxin 1 mu M. Furthermore, the cAMP accumulation stimulated by forskolin 10 mu M was determined in guinea-pig hippocampal membranes. We used the following drugs: the cannabinoid receptor agonists (-)-cis-3-[2-hydroxy-4-(1,1-dimethyrheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol(CP-55,940) and R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone (WIN 55,212-2), the inactive S(-)-enantiomer of the latter (WIN 55,212-3) and the CB1 receptor antagonist N-piperidino-5-(4-chlorophenyl)-1-(2 ,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide (SR 141716). The electrically evoked tritium overflow from guinea-pig hippocampal slices was reduced by WIN 55,212-2 (pIC(30%) 6.5) but not affected by WIN 55,212-3 up to 10 mu M The concentration-response curve of WIN 55,212-2 was shifted to the right by SR 141716 (0.032 mu M) (apparent pA(2) 8.2), which by itself did not affect the evoked overflow. WIN 55,212-2 1 mu M also inhibited the Ca2+-evoked tritium overflow in guinea-pig hippocampal slices and the electrically evoked overflow in guinea-pig cerebellar, cerebrocortical and hypothalamic slices as well as in human hippocampal slices but not in rat and mouse hippocampal slices. SR 141716 (0.32 mu M) markedly attenuated the WIN 55,212-2-induced inhibition in guinea-pig and human brain slices. SR 141716 0.32 mu M by itself increased the electrically evoked tritium overflow in guinea-pig hippocampal slices but failed to do so in slices from the other brain regions of the guinea-pig and in human hippocampal slices. The cAMP accumulation stimulated by forskolin was reduced by CP-55,940 and WIN 55,212-2. The concentration-response curve of CP 55,940 was shifted to the right by SR 141716 (0.1 mu M; apparent pA(2) 8.3), which by itself did not affect cAMP accumulation. In conclusion, cannabinoid receptors of the CB1 subtype occur in the human hippocampus, where they may contribute to the psychotropic effects of cannabis, and in the guinea-pig hippocampus, cerebellum, cerebral cortex and hypothalamus. The CB1 receptor in the guinea-pig hippocampus is located presynaptically, is activated by endogenous cannabinoids and may be negatively coupled to adenylyl cyclase.
引用
收藏
页码:583 / 589
页数:7
相关论文
共 23 条
  • [11] STRUCTURE OF A CANNABINOID RECEPTOR AND FUNCTIONAL EXPRESSION OF THE CLONED CDNA
    MATSUDA, LA
    LOLAIT, SJ
    BROWNSTEIN, MJ
    YOUNG, AC
    BONNER, TI
    [J]. NATURE, 1990, 346 (6284) : 561 - 564
  • [12] SEARCH FOR ENDOGENOUS LIGANDS OF THE CANNABINOID RECEPTOR
    MECHOULAM, R
    HANUS, L
    MARTIN, BR
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (08) : 1537 - 1544
  • [13] MOLECULAR CHARACTERIZATION OF A PERIPHERAL RECEPTOR FOR CANNABINOIDS
    MUNRO, S
    THOMAS, KL
    ABUSHAAR, M
    [J]. NATURE, 1993, 365 (6441) : 61 - 65
  • [14] EFFECT OF PHENYLMETHYLSULFONYL FLUORIDE ON THE POTENCY OF ANANDAMIDE AS AN INHIBITOR OF ELECTRICALLY-EVOKED CONTRACTIONS IN 2 ISOLATED TISSUE PREPARATIONS
    PERTWEE, RG
    FERNANDO, SR
    GRIFFIN, G
    ABADJI, V
    MAKRIYANNIS, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 272 (01) : 73 - 78
  • [15] Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder
    Pertwee, RG
    Fernando, SR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) : 2053 - 2058
  • [16] BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF SR141716A, THE FIRST POTENT AND SELECTIVE BRAIN CANNABINOID RECEPTOR ANTAGONIST
    RINALDICARMONA, M
    BARTH, F
    HEAULME, M
    ALONSO, R
    SHIRE, D
    CONGY, C
    SOUBRIE, P
    BRELIERE, JC
    LEFUR, G
    [J]. LIFE SCIENCES, 1995, 56 (23-24) : 1941 - 1947
  • [17] SR141716A, A POTENT AND SELECTIVE ANTAGONIST OF THE BRAIN CANNABINOID RECEPTOR
    RINALDICARMONA, M
    BARTH, F
    HEAULME, M
    SHIRE, D
    CALANDRA, B
    CONGY, C
    MARTINEZ, S
    MARUANI, J
    NELIAT, G
    CAPUT, D
    FERRARA, P
    SOUBRIE, P
    BRELIERE, JC
    LEFUR, G
    [J]. FEBS LETTERS, 1994, 350 (2-3): : 240 - 244
  • [18] Cannabinoid receptor-mediated inhibition of dopamine release in the retina
    Schlicker, E
    Timm, J
    Gothert, M
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 354 (06) : 791 - 795
  • [19] Mutual interactions of the presynaptic histamine H-3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain
    Schlicker, E
    Marr, I
    [J]. NEUROSCIENCE, 1997, 79 (01) : 247 - 254
  • [20] Shen MX, 1996, J NEUROSCI, V16, P4322